Raymond James & Associates’s Nuveen Corporate Income 2023 Target Term Fund JHAA Stock Holding History

Raymond James & Associates’s Portfolio JHAA Stock Details JHAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,589	Closed	-$111K	–	3998
2023 Q3	$111K	Buy	11,589 +666	+6%	+$6.29K	﹤0.01%	3581
2023 Q2	$102K	Buy	+10,923	New	+$101K	﹤0.01%	3628

Raymond James & Associates's JHAA Position: Q4 2023 in Review

Raymond James & Associates sold out of Nuveen Corporate Income 2023 Target Term Fund (JHAA) in Q4 2023, closing a stake of 11,589 shares — an estimated $111K sold.

Raymond James & Associates first reported a position in JHAA in Q2 2023 and held it in 2 quarters. The position peaked at $111K in Q3 2023. 0 funds tracked by Wall St. Rank hold JHAA as of Q4 2023.

Raymond James & Associates reported no remaining Nuveen Corporate Income 2023 Target Term Fund position as of Q4 2023 after selling out during the quarter.
Raymond James & Associates sold 11,589 Nuveen Corporate Income 2023 Target Term Fund shares in Q4 2023, an estimated $111K.
Raymond James & Associates first reported a position in Nuveen Corporate Income 2023 Target Term Fund in Q2 2023 and held it in 2 quarters.
Raymond James & Associates's Nuveen Corporate Income 2023 Target Term Fund position peaked at $111K in Q3 2023.
0 funds tracked by Wall St. Rank held Nuveen Corporate Income 2023 Target Term Fund as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.